Informing Clinical Practice Today: Core Insights from Psychedelic-Assisted Psychotherapy

A 3-part series led by Ronald Siegel

Research on Psychedelic-Assisted Psychotherapy (PAP) has mushroomed in the past few years, offering not only possible breakthrough treatments for PTSD, depression, addictions and end-of-life anxiety, but also providing new insights into the nature of psychological distress and mechanisms of healing.

What can clinicians learn from these investigations? How can they inform our practice if we’re not participating in the research? How do the learnings from PAP about leaning into experience, acceptance, attachment, forgiveness and connectedness help therapists’ practices right now?

PART 1:

Mindfulness, Self-Compassion & Psychedelic-Assisted Psychotherapy

Live Broadcast Date: Thursday, February 18
Live Broadcast Time: 1:15 pm – 4:30 pm ET
Registration Fees: $132/workshop or special price $325 for all 3 (regular price $396)

All registrations include:

  • Individual entrance to the live, interactive webinar
  • 1 year of recorded archive access
  • Certificate of Participation showing hours attended

In this 3-hour interactive webinar, you’ll learn practical tools and techniques derived from psychedelic-assisted psychotherapy to help clients with a wide array of disorders. We’ll explore ways to help clients integrate split-off traumatic memories, open their hearts, embrace vulnerability, surrender to the flow of everchanging experience, move from isolation to deep connection with people and nature, appreciate the unreliable fluidity of thought and find meaning in everyday moments.

You’ll learn how to use mindfulness and self-compassion practices along with other techniques to harness these healing mechanisms, while also gaining the knowledge necessary to help clients who might be experimenting with psychedelics to integrate and grow from their experiences.

You will learn—

  • To identify the common elements in a wide variety of psychological disorders
  • How mindfulness practices work to resolve psychological distress
  • The role of compassion and self-compassion in psychotherapeutic progress
  • How evidence supports the efficacy and mechanisms of action in psychedelic-assisted psychotherapy
  • The role of transpersonal or “mystical” experience in both mindfulness-informed and psychedelic-assisted psychotherapy
  • Practical ways to introduce the transformative elements of mindfulness and compassion-informed, and psychedelic-assisted sessions into other forms of psychotherapy

PART 2:

Learnings from a Lifetime of Therapeutic Practice: Insights and Potential of Ketamine-Assisted Psychotherapy

Live Broadcast Date: Thursday, February 25
Live Broadcast Time: 1:00 pm – 4:15 pm ET
Registration Fees: $132/workshop or special price $325 for all 3 (regular price $396)

All registrations include:

  • Individual entrance to the live, interactive webinar
  • 1 year of recorded archive access
  • Certificate of Participation. For more CE information, click here

Phil Wolfson’s clinical psychiatry/psychotherapy practice has focused on new pathways for healing for decades. His clinical practice with ketamine has informed his prominent leadership role in the development of Ketamine Assisted Psychotherapy (KAP).  In conversation with Ronald Siegel, Phil will discuss insights from his career, KAP research findings, the transformative nature of therapy and the therapist-client relationship. Learn how these insights can help inform your practice, while providing deeper patient relationships.

PART 3:

Psilocybin in End-Of-Life Care: New Perspectives on Anxiety and Depression

Live Broadcast Date: Thursday, March 4
Live Broadcast Time: 1:00 pm – 4:15 pm ET
Registration Fees: $132/workshop or special price $325 for all 3 (regular price $396)

All registrations include:

  • Individual entrance to the live, interactive webinar
  • 1 year of recorded archive access
  • Certificate of Participation. For more CE information, click here

Join Dr. Bossis and Ronald Siegel as they review learnings from Dr. Bossis’ research on the effects of psilocybin found in a specific species of mushrooms.  Learn about a landmark clinical trial that demonstrated a significant reduction in depression and anxiety from a single psilocybin-generated mystical experience in persons with cancer, as well as findings from Dr. Bossis’ current work with the dying. You will hear about implications for psychotherapists including “the holding environment“ in therapy and the importance of connectedness and the possibilities of “letting go”. Hear how therapy has been shown to alleviate end-of-life distress, enhance psychological well-being, treat a myriad of mental health disorders and provide a deeper understanding of meaning and spirituality.

Event Detail

March 4, 2021 1:00 pm
March 4, 2021 4:30 pm